UCSF

Study uncovers unidentified lung disease in smokers with COPD-like symptoms but standard tests proving negative.

UC San Francisco researchers find glioblastoma tumors’ neural activity reshapes surrounding brain tissue, suggesting gabapentin as a potential treatment.

Study by UC San Francisco links long waits in California’s emergency rooms to increased patient demand outpacing department capacity.

Revolutionary Alzheimer’s drug, donanemab, shows potential in slowing cognitive decline, calls for cautious optimism due to potential side effects.

Scientists develop powerful new drug candidates inspired by ibogaine for addiction and depression treatment, without harmful side effects.

Scientists discover genetic variant linked to faster progression of multiple sclerosis, leading to new treatment possibilities.

Blood protein fibrin identified as catalyst for brain diseases, transforming beneficial immune cells into harmful ones. Potential for new therapies.

How the pandemic lockdown increased breastfeeding duration: Study finds American mothers breastfed babies for 2 additional weeks due to stay-at-home …

UC San Francisco researchers uncover a new brain circuit involving astrocytes that helps regulate attention and stress responses.

Research from UC San Francisco has unveiled the chemical industry’s efforts to hide the dangers of PFAS (“forever chemicals”), in…